CphI & P-Mec India

The drug is expected to be available from December, was approved both as a tablet and an injection

The trials shows the efficacy and safety of biosimilar adalimumab

The Basel-based drugmaker hopes this latest analysis lends RTH258 additional muscle when matched head-to-head with Eylea

J&J said the results were strong enough to advance Stelara into larger Phase III testing

Suresh Pareek, MD, Ideal Cures, in an interaction with Express Pharma, talks about the uniqueness of INSTACOAT 4G, which was…

Risk-based monitoring (RBM) adoption is building momentum as pharma companies and CROs are shifting focus and are developing…

Daniel Zakowiecki, Marek Lachmann and Tobias Heß Chemische Fabrik Budenheim, in this article outlines the most important…

The patients, all of whom had an occlusion of the intracranial internal carotid or proximal middle cerebral artery, were treated…

The vaccine developed by Bharat Biotech could also be used safely in babies

Suresh Pareek, MD, Ideal Cures and Sanjay Negi, DGM Film Coatings, Ideal Cures, give an insight the coating performance of IDEAL…